Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K200102
    Manufacturer
    Date Cleared
    2020-09-03

    (230 days)

    Product Code
    Regulation Number
    872.3640
    Panel
    Dental
    Reference & Predicate Devices
    Predicate For
    N/A
    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    MIS Dental Implant Systems are intended to be surgically placed in the bone of the upper or lower jaw arches to provide support for prosthetic devices, such as artificial teeth, in order to restore masticatory function. When a one-stage surgical procedure is applied, the implant may be immediately loaded when good primary stability is achieved, and the occlusal load is appropriate.

    Narrow implants (Ø3.3mm) are indicated for use in surgical and restorative applications for placement only in the mandibular central, lateral incisor and maxillary lateral incisor regions of partially edentulous jaws, to provide support for prosthetic devices such as artificial teeth. Mandibular central and lateral incisors must be splinted if using two or more narrow implants adjacent to one another.

    The long MIS (18 & 20 mm) implants can be used in a tilted manner.

    MIS short implants are to be used only with straight abutments. M4 short implants are indicated for delayed loading only.

    Device Description

    The subject MIS Dental Implant Systems are endosseous dental implant devices which are modified as subject to this premarket notification with a revised sterile packaging configuration. There are no modifications subject to this premarket notification which relate to the geometric or material composition design of the subject dental implant devices themselves. The individual product variants of the MIS Dental Implant Systems which are modified as subject to this premarket notification will be rebranded "MIS CLEAR". The subject implants are identical to the predicate and reference MIS implant systems in terms of their indications for use, design, constituent materials and manufacturing process. The subject MIS Dental Implants Systems only differ in their final packaging configuration, as subject to this premarket notification. The subject, predicate and reference MIS Dental Implants Systems are supplied in a double tube packaging configuration, wherein the outer tube serves as the sterile barrier, and the implant device is located within the inner tube. While the predicate and reference MIS Dental Implants Systems are supplied within a "dry" inner package tube, the subject devices as modified in this premarket notification are supplied in a modified inner tube containing liquid, in the form of NaCl solution. The liquid environment is intended to maintain the super-hydrophilic property (contact angle exhibited by water in contact with the surface is equal to zero degrees) of the subject MIS Dental Implants Systems, as subject to this premarket notification, until their use in patients. The outer tube serving as the sterile barrier is unchanged compared to the predicate and reference devices.

    AI/ML Overview

    The provided context describes a 510(k) premarket notification for MIS Dental Implant Systems. The primary change being assessed is a modification to the inner packaging of the implants, specifically, the introduction of an NaCl solution to maintain the super-hydrophilic property of the implants.

    Here's an analysis of the acceptance criteria and supporting studies based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    The document does not explicitly present a table of predetermined acceptance criteria. Instead, it describes various non-clinical tests performed and states that the data supports the desired outcome. The device's performance, as reported, is that it meets the requirements of these tests.

    Test TypeReported Device Performance
    CytotoxicityNo toxic effects observed after one year accelerated shelf-life simulation.
    Chemical CharacterizationNo foreign or unexpected materials present after one year accelerated shelf-life simulation.
    SterilizationAchieves sterility assurance level (SAL) of at least 10^-6^ in accordance with ISO 11137-1:2015 and ISO 11137-2:2015.
    TransportationSurvives transportation conditions in accordance with ASTM 4332-14 and ASTM D 4169-16.
    HydrophilicitySuper-hydrophilic properties maintained after one year accelerated shelf-life.
    Fatigue TestingMechanical endurance limit of implants is unaffected by NaCl environment (referenced from predicate device studies).

    2. Sample Size Used for the Test Set and Data Provenance

    The document does not specify the sample sizes used for each non-clinical test mentioned (e.g., number of implants tested for cytotoxicity).

    The data provenance is from non-clinical bench testing performed to support this premarket notification. The country of origin of the data is not specified, but the applicant, Dentsply Sirona, is based in York, Pennsylvania, USA, and MIS Implants Technologies Ltd. (a Dentsply Sirona company) is listed as the manufacturer.

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications

    This section is not applicable because the studies detailed are non-clinical (bench testing) rather than clinical studies involving human observers or expert interpretation. Therefore, there was no ground truth requiring expert consensus.

    4. Adjudication Method for the Test Set

    This section is not applicable as the studies are non-clinical bench tests and do not involve human adjudication.

    5. Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study

    No. A Multi-Reader Multi-Case (MRMC) comparative effectiveness study was not done. The document explicitly states: "No human clinical data was included in this premarket notification to support the substantial equivalence..."

    6. Standalone (Algorithm Only Without Human-in-the-Loop Performance) Study

    This question is not applicable as the device is a physical dental implant system, not an algorithm or AI software for which standalone performance would be assessed.

    7. Type of Ground Truth Used

    For the non-clinical performance data, the "ground truth" or reference criteria would be defined by the standards and methods used for each test:

    • Cytotoxicity: Negative control or established biocompatibility standards.
    • Chemical Characterization: Baseline material composition and absence of unexpected leachables.
    • Sterilization: Sterility assurance level (SAL) of 10^-6^ as per ISO 11137-1:2015 and ISO 11137-2:2015.
    • Transportation: No damage or compromise to packaging or device integrity after simulated transport, as per ASTM 4332-14 and ASTM D 4169-16.
    • Hydrophilicity: Maintenance of super-hydrophilic properties (contact angle of water is zero degrees).
    • Fatigue Testing: Mechanical endurance limits established by ISO 14801:2016 for dental implants (referenced from predicate devices).

    8. Sample Size for the Training Set

    This section is not applicable. There is no "training set" as this is a physical medical device, not an AI/ML algorithm that requires training data.

    9. How the Ground Truth for the Training Set Was Established

    This section is not applicable for the same reason as above.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1